PeptiDream Inc. 4587Short Interest
Estimated short interest in PeptiDream Inc. (4587) is 1.26% of shares outstanding as of 2026-11-18. Institutions holding 0.5% or more: Morgan Stanley MUFG Securities Co., Ltd., GOLDMAN SACHS INTERNATIONAL.
Estimated short interest
1.26%
±0.00%
Estimated position (shares)
1,645,773
As of 2026-11-18
Holders (0.5% or more)
2 firms
1231 reports
Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 15 institutions that fell below 0.5%. How estimates are calculated
Disclosure History Summary
| First disclosure | 2017-08-30 |
|---|---|
| Latest disclosure | 2026-11-17 (Morgan Stanley MUFG Securities Co., Ltd., 0.70%) |
| Reporting institutions | 18 firms (1231 reports) |
| Peak estimated short interest | 7.40% (2018-01-05, 6 holders) |
Short Interest Trend Last 5 years, by institution, % of shares outstanding
Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.
- Morgan Stanley MUFG Securities Co., Ltd.
- GOLDMAN SACHS INTERNATIONAL
- Integrated Core Strategies (Asia) Pte. Ltd.
- JPM Securities Japan Co Ltd.
- Barclays Capital Securities Ltd
- Others
1.26%
Estimated short interest, 2026-11-18
GOLDMAN SACHS INTERNATIONAL0.56%
Morgan Stanley MUFG Securities Co., Ltd.0.70%
Current Positions by Short Seller Latest report of each holder
| Last report | Short seller | Position (shares) | Ratio | Change | Status |
|---|---|---|---|---|---|
| 2026-11-17 | Morgan Stanley MUFG Securities Co., Ltd. | Position 910,296 shares | Ratio 0.70% | ▲0.10% | Holding |
| 2026-11-16 | GOLDMAN SACHS INTERNATIONAL | Position 735,477 shares | Ratio 0.56% | ▼0.05% | Holding |
| 2019-02-20 | Deutsche Bank Aktiengesellschaft, London | Position 609,900 shares | Ratio 0.49% | ▼0.10% | Below 0.5% |
| 2024-01-10 | Arrowstreet Capital Global Equity Long/Short Fund Limited | Position 631,300 shares | Ratio 0.48% | ▼0.04% | Below 0.5% |
| 2017-09-11 | Myriad Opportunities Master Fund Limited | Position 541,500 shares | Ratio 0.47% | ▼0.03% | Below 0.5% |
| 2026-04-06 | MERRILL LYNCH INTERNATIONAL | Position 618,549 shares | Ratio 0.47% | ▼0.04% | Below 0.5% |
| 2026-03-23 | JPM Securities Japan Co Ltd. | Position 614,000 shares | Ratio 0.47% | ▼0.04% | Below 0.5% |
| 2021-11-17 | ExodusPoint Capital Management Singapore, Pte. Ltd. | Position 612,100 shares | Ratio 0.47% | ▼0.10% | Below 0.5% |
| 2022-03-25 | AQR Capital Management, LLC | Position 595,100 shares | Ratio 0.45% | ▼0.06% | Below 0.5% |
| 2026-09-25 | Citigroup Global Markets Limited | Position 591,066 shares | Ratio 0.45% | ▼0.06% | Below 0.5% |
| 2026-05-12 | Barclays Capital Securities Ltd | Position 583,066 shares | Ratio 0.44% | ▼0.13% | Below 0.5% |
| 2018-11-12 | Credit Suisse Securities (Europe) Limited | Position 518,593 shares | Ratio 0.41% | ▼0.16% | Below 0.5% |
| 2025-09-05 | Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. | Position 432,475 shares | Ratio 0.33% | ▼0.34% | Below 0.5% |
| 2026-08-28 | Nomura International plc | Position 417,868 shares | Ratio 0.32% | ▼0.19% | Below 0.5% |
| 2019-04-01 | Mizuho Securities Co., Ltd. | Position 185,500 shares | Ratio 0.14% | ▼0.38% | Below 0.5% |
| 2022-07-28 | Integrated Core Strategies (Asia) Pte. Ltd. | Position 109,300 shares | Ratio 0.08% | ▼0.82% | Below 0.5% |
| 2018-01-11 | UBS AG | Position 73,700 shares | Ratio 0.06% | ▼0.51% | Below 0.5% |
| 2024-09-18 | Societe Generale | Position 0 shares | Ratio 0.00% | ▼0.81% | Closed |
Disclosure History 1231 in total
| Trade date | Short seller | Position (shares) | Ratio | Change | Note |
|---|---|---|---|---|---|
| 2026-11-17 | Morgan Stanley MUFG Securities Co., Ltd. | Position 910,296 shares | Ratio 0.70% | ▲0.10% | — |
| 2026-11-16 | GOLDMAN SACHS INTERNATIONAL | Position 735,477 shares | Ratio 0.56% | ▼0.05% | — |
| 2026-11-13 | Morgan Stanley MUFG Securities Co., Ltd. | Position 791,612 shares | Ratio 0.60% | ▲0.03% | — |
| 2026-11-11 | GOLDMAN SACHS INTERNATIONAL | Position 794,277 shares | Ratio 0.61% | ▲0.02% | — |
| 2026-11-09 | GOLDMAN SACHS INTERNATIONAL | Position 769,169 shares | Ratio 0.59% | ▼0.10% | — |
| 2026-11-04 | Morgan Stanley MUFG Securities Co., Ltd. | Position 753,312 shares | Ratio 0.57% | ▲0.09% | — |
| 2026-11-02 | Morgan Stanley MUFG Securities Co., Ltd. | Position 630,602 shares | Ratio 0.48% | ▼0.08% | Below 0.5% |
| 2026-10-30 | GOLDMAN SACHS INTERNATIONAL | Position 909,769 shares | Ratio 0.69% | ▼0.01% | — |
| 2026-10-28 | Morgan Stanley MUFG Securities Co., Ltd. | Position 728,402 shares | Ratio 0.56% | ▼0.04% | — |
| 2026-10-27 | Morgan Stanley MUFG Securities Co., Ltd. | Position 791,302 shares | Ratio 0.60% | ▲0.03% | — |
| 2026-10-21 | Morgan Stanley MUFG Securities Co., Ltd. | Position 743,302 shares | Ratio 0.57% | ▼0.11% | — |
| 2026-10-14 | GOLDMAN SACHS INTERNATIONAL | Position 910,669 shares | Ratio 0.70% | ▲0.10% | — |
| 2026-10-06 | Morgan Stanley MUFG Securities Co., Ltd. | Position 894,278 shares | Ratio 0.68% | ▼0.10% | — |
| 2026-09-30 | Morgan Stanley MUFG Securities Co., Ltd. | Position 1,023,446 shares | Ratio 0.78% | ▼0.16% | — |
| 2026-09-28 | Morgan Stanley MUFG Securities Co., Ltd. | Position 1,227,246 shares | Ratio 0.94% | ▲0.05% | — |
| 2026-09-25 | Citigroup Global Markets Limited | Position 591,066 shares | Ratio 0.45% | ▼0.06% | Below 0.5% |
| 2026-09-24 | Morgan Stanley MUFG Securities Co., Ltd. | Position 1,169,486 shares | Ratio 0.89% | ▼0.01% | — |
| 2026-09-17 | Citigroup Global Markets Limited | Position 671,066 shares | Ratio 0.51% | ▲0.11% | — |
| 2026-09-16 | Morgan Stanley MUFG Securities Co., Ltd. | Position 1,176,986 shares | Ratio 0.90% | ▲0.03% | — |
| 2026-09-14 | Morgan Stanley MUFG Securities Co., Ltd. | Position 1,143,886 shares | Ratio 0.87% | ▼0.04% | — |
| 2026-09-10 | GOLDMAN SACHS INTERNATIONAL | Position 784,669 shares | Ratio 0.60% | ▲0.08% | — |
| 2026-09-09 | Morgan Stanley MUFG Securities Co., Ltd. | Position 1,195,386 shares | Ratio 0.91% | ▲0.02% | — |
| 2026-09-08 | Morgan Stanley MUFG Securities Co., Ltd. | Position 1,169,986 shares | Ratio 0.89% | ▼0.05% | — |
| 2026-09-07 | Morgan Stanley MUFG Securities Co., Ltd. | Position 1,226,526 shares | Ratio 0.94% | ▼0.16% | — |
| 2026-09-01 | Morgan Stanley MUFG Securities Co., Ltd. | Position 1,442,026 shares | Ratio 1.10% | ▲0.03% | — |
| 2026-08-31 | Morgan Stanley MUFG Securities Co., Ltd. | Position 1,403,026 shares | Ratio 1.07% | ▼0.07% | — |
| 2026-08-31 | GOLDMAN SACHS INTERNATIONAL | Position 682,269 shares | Ratio 0.52% | ▲0.03% | — |
| 2026-08-28 | Nomura International plc | Position 417,868 shares | Ratio 0.32% | ▼0.19% | Below 0.5% |
| 2026-08-28 | GOLDMAN SACHS INTERNATIONAL | Position 648,569 shares | Ratio 0.49% | ▼0.04% | Below 0.5% |
| 2026-08-27 | Nomura International plc | Position 673,133 shares | Ratio 0.51% | ▲0.06% | — |
Shorted Stocks in the Same Industry Pharmaceutical
| Stock | Estimated ratio | Short sellers |
|---|---|---|
| GNI Group Ltd.2160 | 11.16% | 7 firms |
| Oncolys BioPharma Inc.4588 | 10.35% | 7 firms |
| HEALIOS K.K.4593 | 10.20% | 5 firms |
| SymBio Pharmaceuticals Limited4582 | 9.46% | 7 firms |
| Nxera Pharma Co.,Ltd.4565 | 7.35% | 5 firms |
Related Stocks Same TSE 33 sector
| Stock | Market | TSE 33 Sector | TOPIX-17 Sector | Index |
|---|---|---|---|---|
| RaQualia Pharma Inc.4579 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| SymBio Pharmaceuticals Limited4582 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Chiome Bioscience Inc.4583 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Kidswell Bio Corporation4584 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Medrx Co.,Ltd.4586 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| Oncolys BioPharma Inc.4588 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| RIBOMIC Inc.4591 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| SanBio Company Limited4592 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| HEALIOS K.K.4593 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical | |
| BrightPath Biotherapeutics Co.,Ltd.4594 | Growth Market(Domestic) | Pharmaceutical | Pharmaceutical |